Charming Medical Limited Class A Ordinary Shares (MCTA) Earnings History
Profitable3 years of earnings data (2022–2024) · Positive TTM net income
Loading earnings history...
Charming Medical Limited Class A Ordinary Shares (MCTA) Earnings Overview
As of June 30, 2026, Charming Medical Limited Class A Ordinary Shares (MCTA) reported trailing twelve-month net income of $1M, reflecting +54.2% year-over-year growth. The company earned $0.07 per diluted share over the past four quarters, with a net profit margin of 19.3%.
Looking at the long-term picture, MCTA's historical earnings data spans multiple years. The company achieved its highest annual net income of $1M in fiscal 2024, representing a new all-time high.
Charming Medical Limited Class A Ordinary Shares maintains industry-leading profitability with a gross margin of 67.2%, operating margin of 22.3%, and net margin of 19.3%. This margin structure demonstrates strong pricing power and operational efficiency. View revenue history →
Compared to peers including CANG (-$2.46B net income, -65.8% margin), CLOV (-$57M net income, -4.4% margin), ACMR ($91M net income, 10.4% margin), MCTA has outperformed on profitability metrics. Compare MCTA vs CANG →
MCTA Earnings vs Peers
Earnings metrics vs comparable public companies
MCTA Historical Earnings Data (2022–2024)
3 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | $1M | +54.2% | $1M | $0.07 | 19.3% | 22.3% |
| 2023 | $777,811 | +354.9% | $1M | $0.05 | 12.9% | 16.8% |
| 2022 | $-305,117 | - | $-521,336 | $-0.02 | -8.6% | -14.8% |
Download Data
Export MCTA earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
4+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
MCTA — Frequently Asked Questions
Quick answers to the most common questions about buying MCTA stock.
What is MCTA earnings per share (EPS)?
MCTA trailing twelve-month (TTM) diluted EPS is $0.07, reflecting +54.2% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2022 to 2024 is available in the table on this page.
What is Charming Medical Limited Class A Ordinary Shares's net income?
Charming Medical Limited Class A Ordinary Shares (MCTA) trailing twelve-month net income is $1M as of 2024. Earnings grew +54.2% year-over-year. Charming Medical Limited Class A Ordinary Shares has been profitable for 2 consecutive years.
Is MCTA profitable?
Yes, MCTA is profitable with a TTM net income of $1M and a net profit margin of +19.3%. Charming Medical Limited Class A Ordinary Shares has generated profits for 2 consecutive years.
What is MCTA's earnings growth rate?
MCTA compound annual EPS growth rates (CAGR): 1-Year: +54.2%, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2022 to 2024.
What are MCTA's profit margins?
Charming Medical Limited Class A Ordinary Shares net profit margin is +19.3%, operating margin is +22.3%, and gross margin is +67.2%. Above-average net margins reflect strong pricing power and competitive moat. Return on Equity is +2435.0%.
Is MCTA growing earnings?
Yes, MCTA earnings are accelerating — EPS growth of +54.2% exceeds the 5-year CAGR of N/A. TTM net income reached $1M. Earnings momentum is strengthening.
What was MCTA's best earnings year?
Charming Medical Limited Class A Ordinary Shares's highest annual net income on record is $1M, achieved in fiscal year 2024. Earnings history on this page spans 2022 to 2024 and includes all annual and quarterly figures.